Abstract:Simple and scalable synthetic approach was used for the preparation of thirteen novel tacrine derivatives consisting of tacrine and N -aryl-piperidine-4-carboxamide moiety connected by a five-methylene group linker. An anti-Alzheimer disease (AD) potential of newly designed tacrine derivatives was evaluated against two important AD targets, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). In vitro pharmacological evaluation showed strong ChE inhibitory activity of all compounds, with IC 50 values ranging from 117.5 to 455 nM for AChE and 34 to 324 nM for BuChE. As a representative of the series with the best cytotoxicity / ChE inhibitory activity ratio, expressed as the selectivity index (SI), 2-chlorobenzoyl derivative demonstrated mixed-type inhibition on AChE and BuChE, suggesting binding to both CAS and PAS of the enzymes. It also exhibited antioxidant capacity and neuroprotective potential against amyloid-β (Aβ) toxicity in the culture of neuron-like cells. In-depth computational analysis corroborated well with in vitro ChE inhibition, illuminating that all compounds exhibit significant potential in targeting both enzymes. Molecular dynamics (MD) simulations revealed that 2-chlorobenzoyl derivative, created complexes with AChE and BuChE that demonstrated sufficient stability throughout the observed MD simulation. Computationally predicted ADME properties indicated that these compounds should have good blood-brain barrier (BBB) permeability, an important factor for CNS-targeting drugs. Overall, all tested compounds showed promising pharmacological behavior, highlighting the multi-target potential of 2-chlorobenzoyl derivative which should be further investigated as a new lead in the drug development process.

Design, Synthesis and Biological Evaluation of Tacrine-1,2,3-triazole Derivatives As Potent Cholinesterase Inhibitors.

Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.

Design, Synthesis and Evaluation of Novel Tacrine-Rhein Hybrids As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Tacrine-hydroxamate Derivatives As Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, and Biological Evaluation.

Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.

Design, Synthesis and Evaluation of Novel Tacrine-Multialkoxybenzene Hybrids As Dual Inhibitors for Cholinesterases and Amyloid Beta Aggregation

Synthesis, Pharmacology and Molecular Docking on Multifunctional Tacrine-Ferulic Acid Hybrids As Cholinesterase Inhibitors Against Alzheimer's Disease

Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer's disease.

Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease

Design, Synthesis and Evaluation of Novel Tacrine Coumarin Hybrids As Multifunctional Cholinesterase Inhibitors Against Alzheimer'S Disease

Late-Stage Modification of Medicine: Pd-Catalyzed Direct Synthesis and Biological Evaluation of N -Aryltacrine Derivatives

Tacrine–propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer’s disease

Design, Synthesis and Biological Evaluation of Multifunctional Tacrine-Curcumin Hybrids As New Cholinesterase Inhibitors with Metal Ions-Chelating and Neuroprotective Property

Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids As Multifunctional Drug Candidates Against Alzheimer’s Disease

Dual functional cholinesterase and PDE4D inhibitors for the treatment of Alzheimer's disease: Design, synthesis and evaluation of tacrine-pyrazolo[3,4-b]pyridine hybrids.

Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease.

Synthesis and Evaluation of Heterobivalent Tacrine Derivatives As Potential Multi-Functional Anti-Alzheimer Agents

Searching for the Multi-Target-Directed Ligands Against Alzheimer’s Disease: Discovery of Quinoxaline-Based Hybrid Compounds with AChE, H3R and BACE 1 Inhibitory Activities

Synthesis and Activity Towards Alzheimer's Disease in Vitro: Tacrine, Phenolic Acid and Ligustrazine Hybrids.

Synthesis, Biological Activity, Molecular Docking Studies of a Novel Series of 3-Aryl-7h-thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives As the Acetylcholinesterase Inhibitors

Multi-Target Potential Of Newly Designed Tacrine-Derived Cholinesterase Inhibitors: Synthesis, Computational And Pharmacological Study